Latest News and Press Releases

Dublin, May 14, 2025 (GLOBE NEWSWIRE) -- The "Bevacizumab - Biosimilar Insight, 2025" has been added to ResearchAndMarkets.com's offering. Bevacizumab - Biosimilar Insight, 2025 offers an...

Dublin, May 14, 2025 (GLOBE NEWSWIRE) -- The "Europe Biosimilars Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user,...

Dublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Biosimilars - Through the Physician's Lens" report has been added to ResearchAndMarkets.com's offering.Since their introduction within the past few...

Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Biosimilars: Global Markets" has been added to ResearchAndMarkets.com's offering. The global biosimilars market is on an impressive growth...

BUENOS AIRES, Argentina, April 16, 2025 (GLOBE NEWSWIRE) -- Biosidus, an Argentinean pioneer company in biotechnology research, development, and the production of high-quality biosimilars, has...

Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "2024 Sales of Therapeutic Antibodies, Proteins, Biosimilars, Gene & Cell Therapy and Therapeutic RNA" report has been added to ...

Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Biosimilars Market - Products, Applications and Regulations" report has been added to ResearchAndMarkets.com's offering. The global biosimilars...

Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033" report has been added to ...

Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Insulin Biosimilar Market by Type of Insulin, by Mode of Administration, by Therapeutic Application, by Distribution Channel, and by Region" report has...

Dublin, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The "Immunology Biosimilars Market (2024 Edition): Analysis By Indication (Arthritis, Irritable Bowel Disease, Other Indications), By Distribution Channel,...